ID

13084

Beskrivning

Vector Delivery of the IL-12 Gene in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00406939

Länk

https://clinicaltrials.gov/show/NCT00406939

Nyckelord

  1. 2016-01-15 2016-01-15 -
Rättsinnehavare

CC BY-NC 3.0

Uppladdad den

15 januari 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostatic Neoplasms NCT00406939

Eligibility Prostatic Neoplasms NCT00406939

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
men who have biopsy-proven local recurrence or persistence of cancer in the prostate gland with or without metastatic disease after the hormone therapy, cryosurgery, and/or the completion of definitive radiation therapy for at least one year.
Beskrivning

prostate cancer

Datatyp

boolean

Alias
UMLS CUI [1]
C0600139
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
Beskrivning

patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.

Datatyp

boolean

Alias
UMLS CUI [1]
C0138741
the patient will possess the ability to give informed consent and express a willingness to meet all the expected requirements of the protocol for the duration of the study. (informed consent document).
Beskrivning

informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
patients must have adequate baseline organ function as assessed by the following laboratory values before initiating the protocol.
Beskrivning

organ function

Datatyp

boolean

Alias
UMLS CUI [1]
C0678852
1. adequate renal function with serum creatinine less than 1.5 mg/dl or creatinine clearance greater than 45 ml/min/m2.
Beskrivning

renal function

Datatyp

boolean

Alias
UMLS CUI [1]
C0201976
2. platelet count greater than 100,000 platelets/mm3.
Beskrivning

platelets

Datatyp

boolean

Alias
UMLS CUI [1]
C0005821
3. absolute neutrophil count greater than 1000/mm3.
Beskrivning

absolute neutrophil count

Datatyp

boolean

Alias
UMLS CUI [1]
C0948762
4. hemoglobin greater than 8.5 mg/dl
Beskrivning

hemoglobin

Datatyp

boolean

Alias
UMLS CUI [1]
C0019046
5. normal partial thromboplastin time (ptt) and pro-thrombin time (pt).
Beskrivning

ptt and pt

Datatyp

boolean

Alias
UMLS CUI [1]
C0030605
6. bilirubin less than 2.5 mg/dl, sgot and sgpt less than 2.0x normal.
Beskrivning

liver function

Datatyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute infection: acute infection is defined as any viral, bacterial or fungal infection, which requires specific therapy.
Beskrivning

infection

Datatyp

boolean

Alias
UMLS CUI [1]
C0009450
symptomatic metastasis.
Beskrivning

metastasis

Datatyp

boolean

Alias
UMLS CUI [1]
C0027627
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months.
Beskrivning

metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671

Similar models

Eligibility Prostatic Neoplasms NCT00406939

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
men who have biopsy-proven local recurrence or persistence of cancer in the prostate gland with or without metastatic disease after the hormone therapy, cryosurgery, and/or the completion of definitive radiation therapy for at least one year.
boolean
C0600139 (UMLS CUI [1])
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
Item
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
boolean
C0138741 (UMLS CUI [1])
informed consent
Item
the patient will possess the ability to give informed consent and express a willingness to meet all the expected requirements of the protocol for the duration of the study. (informed consent document).
boolean
C0021430 (UMLS CUI [1])
organ function
Item
patients must have adequate baseline organ function as assessed by the following laboratory values before initiating the protocol.
boolean
C0678852 (UMLS CUI [1])
renal function
Item
1. adequate renal function with serum creatinine less than 1.5 mg/dl or creatinine clearance greater than 45 ml/min/m2.
boolean
C0201976 (UMLS CUI [1])
platelets
Item
2. platelet count greater than 100,000 platelets/mm3.
boolean
C0005821 (UMLS CUI [1])
absolute neutrophil count
Item
3. absolute neutrophil count greater than 1000/mm3.
boolean
C0948762 (UMLS CUI [1])
hemoglobin
Item
4. hemoglobin greater than 8.5 mg/dl
boolean
C0019046 (UMLS CUI [1])
ptt and pt
Item
5. normal partial thromboplastin time (ptt) and pro-thrombin time (pt).
boolean
C0030605 (UMLS CUI [1])
liver function
Item
6. bilirubin less than 2.5 mg/dl, sgot and sgpt less than 2.0x normal.
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
infection
Item
acute infection: acute infection is defined as any viral, bacterial or fungal infection, which requires specific therapy.
boolean
C0009450 (UMLS CUI [1])
metastasis
Item
symptomatic metastasis.
boolean
C0027627 (UMLS CUI [1])
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months
Item
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months.
boolean
C0023671 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial